The H. elongata lipid extract, but not the S. fusiforme SCF extract, may decrease the AD-associated tau pathology by decreasing the concentration of the AD-associated p-tau variant (Ser202/Thr205). The gene discussed is MAPT; the disease is Alzheimer disease.